American Century Companies’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-65,146
| Closed | -$89.3K | – | 2940 |
|
2025
Q1 | $89.3K | Sell |
65,146
-45,302
| -41% | -$62.1K | ﹤0.01% | 2829 |
|
2024
Q4 | $341K | Buy |
110,448
+12,162
| +12% | +$37.6K | ﹤0.01% | 2641 |
|
2024
Q3 | $757K | Buy |
98,286
+19,590
| +25% | +$151K | ﹤0.01% | 2337 |
|
2024
Q2 | $675K | Buy |
78,696
+219
| +0.3% | +$1.88K | ﹤0.01% | 2330 |
|
2024
Q1 | $623K | Buy |
78,477
+8,068
| +11% | +$64.1K | ﹤0.01% | 2348 |
|
2023
Q4 | $697K | Buy |
70,409
+46,691
| +197% | +$462K | ﹤0.01% | 2227 |
|
2023
Q3 | $267K | Buy |
23,718
+1,826
| +8% | +$20.6K | ﹤0.01% | 2491 |
|
2023
Q2 | $72.7K | Buy |
21,892
+523
| +2% | +$1.74K | ﹤0.01% | 2729 |
|
2023
Q1 | $83.8K | Buy |
21,369
+2,888
| +16% | +$11.3K | ﹤0.01% | 2569 |
|
2022
Q4 | $134K | Sell |
18,481
-27,379
| -60% | -$198K | ﹤0.01% | 2413 |
|
2022
Q3 | $166K | Buy |
+45,860
| New | +$166K | ﹤0.01% | 2265 |
|